MDNA Life Sciences Inc. (MDLS)

MDNA Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Year Ending	TTM	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	0.96	0.96	0.05
Cash & Cash Equivalents	0.96	0.96	0.05
Cash Growth	-	1801.44%	-
Receivables	0.18	0.18	0.06
Inventory	-	-	0.01
Other Current Assets	0.08	0.08	0.23
Total Current Assets	1.22	1.22	0.35
Property, Plant & Equipment	0.35	0.35	0.36
Goodwill and Intangibles	1.56	1.56	1.74
Other Long-Term Assets	0.06	0.06	0
Total Long-Term Assets	1.97	1.97	2.1
Total Assets	3.19	3.19	2.45
Accounts Payable	2.06	2.06	2.03
Deferred Revenue	0.71	0.71	0.47
Current Debt	15.46	15.46	0.71
Other Current Liabilities	1.36	1.36	0.78
Total Current Liabilities	19.59	19.59	4
Long-Term Debt	1.23	1.23	13.48
Total Long-Term Liabilities	1.23	1.23	13.48
Total Liabilities	20.82	20.82	17.48
Total Debt	16.69	16.69	14.19
Debt Growth	-	17.60%	-
Retained Earnings	-45.35	-45.35	-41.56
Comprehensive Income	0.01	0.01	-0.01
Shareholders' Equity	-17.62	-17.62	-15.03
Net Cash / Debt	-15.73	-15.73	-14.14
Working Capital	-18.37	-18.37	-3.65

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).